Correlation Between Shuttle Pharmaceuticals and Sihuan Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Sihuan Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Sihuan Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Sihuan Pharmaceutical Holdings, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Sihuan Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Sihuan Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Sihuan Pharmaceutical.

Diversification Opportunities for Shuttle Pharmaceuticals and Sihuan Pharmaceutical

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Shuttle and Sihuan is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Sihuan Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sihuan Pharmaceutical and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Sihuan Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sihuan Pharmaceutical has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Sihuan Pharmaceutical go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and Sihuan Pharmaceutical

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Sihuan Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Shuttle Pharmaceuticals is 1.31 times less risky than Sihuan Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Sihuan Pharmaceutical Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Sihuan Pharmaceutical Holdings on August 28, 2024 and sell it today you would lose (0.50) from holding Sihuan Pharmaceutical Holdings or give up 5.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy91.6%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  Sihuan Pharmaceutical Holdings

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Sihuan Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Sihuan Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly weak technical indicators, Sihuan Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Shuttle Pharmaceuticals and Sihuan Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and Sihuan Pharmaceutical

The main advantage of trading using opposite Shuttle Pharmaceuticals and Sihuan Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Sihuan Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sihuan Pharmaceutical will offset losses from the drop in Sihuan Pharmaceutical's long position.
The idea behind Shuttle Pharmaceuticals and Sihuan Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets